31 Using a 3D Fiducial Marker System to Advance the Use of 3D Accelerated Partial Breast Irradiation
38 Use of MRI as an Additional Breast Imaging Tool in Patients With Pathological Nipple Discharge and Comparative Sensitivity With Ultrasound (5-year retrospective study)
2 Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in a Multinational Region Located in the Southeast of the European Part of Russia
3 Analysis of Exhaled Volatile Organic Compounds: A New Frontier in Breast Cancer Screening and Surveillance
15 TiP The FLEX Real-World Data Platform Explores New Gene Expression Profiles and Investigator-Initiated Protocols in Early-Stage Breast Cancer
16 Improving Electronic Medical Record (EMR) Documentation of Genomic Test Scores for Patients With Breast Cancer
32 Triple-Negative Breast Cancer and Pathological Complete Response: A Study of Racial Disparities
34 Demographics, Clinical Characteristics, and Treatment Patterns for Patients With BRCA-Mutated, HER2-Negative Early-Stage Breast Cancer: a CancerLinQ Real-World US Study
39 Delay in Presentation and Management of Patients With Breast Cancer in Baghdad, Iraq
47 A Biomarker Assay Predicts Women Diagnosed With DCIS Without Microinvasion Are at Increased Risk for Breast Cancer– Specific Death
48 TiP - The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients With DCIS Following Breast- Conserving Therapy
55 - BC200 RNA Changes in Breast Cancer Patients After Treatment
